NCT00003229View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal

PHASE1/PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 1997

Primary Completion Date

April 30, 2000

Study Completion Date

February 28, 2005

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL

aldesleukin

BIOLOGICAL

gp100 antigen

BIOLOGICAL

tyrosinase peptide

Trial Locations (2)

22908

Cancer Center, University of Virginia HSC, Charlottesville

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER

NCT00003229 - Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal | Biotech Hunter | Biotech Hunter